FDA Rejects Call for Lipitor, Crestor Muscle Injury Black Box Warning
The FDA has denied a petition for a black box warning on all statin cholesterol drugs that would warn patients of the risk of potentially fatal muscle injuries.
The FDA has denied a petition for a black box warning on all statin cholesterol drugs that would warn patients of the risk of potentially fatal muscle injuries.
A new study that was meant to establish the effectiveness of the cholesterol drug Niaspan, had to be stopped because too many patients dropped out after suffering side effects, such…